Skip to main content

Severe Sinus Pain and Congestion

NDC 51316-927 · CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED

Generic nameAcetaminophen, Guaifenesin, Phenylephrine HCl
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Strength325; 200; 5 mg/1; mg/1; mg/1
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

51316-927-08 — 2 BLISTER PACK in 1 CARTON (51316-927-08) / 12 TABLET, FILM COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51316-815 — Dextromethorphan HBr, guaifenesin, Phenylephrine HCl, 51316-826 — Dextromethorphan Hydrobromide, Guaifenesin, 51316-830 — Dextromethorphan hydrobromide, Guaifenesin, 51316-858 — dextromethorphan hydrobromide, guaifenesin, 51316-863 — Acetaminophen, Diphenhydramine HCL, 51316-878 — guaifenesin and pseudoephedrine hydrochloride, 51316-884 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate, 51316-896 — Acetaminophen Dextromethorphan HBr Phenylephrine HCl, 51316-897 — Acetaminophen, Dextromethorphan HBr, 51316-921 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate, 51316-940 — Acetaminophen, Guaifenesin, 51316-945 — Acetaminophen, Chlorpheniramine Maleate and Dextromethophan HBr, 51316-955 — Acetaminophen and Ibuprofen, 51316-963 — Acetaminophen, Dextromethorphan HBr, Triprolidine HCl, 51316-969 — Acetaminophen 650mg, 51316-970 — guaifenesin and pseudoephedrine hydrochloride, 51316-993 — Guaifenesin and Pseudoephedrine Hydrochloride, 51352-189 — Acetaminophen, Guaifenesin, Pentoxyverine citrate, Phenylpehrine Hydcrochloride, Chlorpheniramine Maleate, Caffeine Anhydrous, 51376-130 — Acetaminophen, 51407-556 — Butalbital, Acetaminophen and Caffeine, +4982 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.